NCT01324115View on ClinicalTrials.gov

NG-Nitro-L-Arginine in Treating Patients With Advanced Solid Tumors

PHASE1TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

NG-nitro-L-arginine

OTHER

laboratory biomarker analysis

OTHER

pharmacological study

PROCEDURE

computed tomography

PROCEDURE

dynamic contrast-enhanced magnetic resonance imaging

Trial Locations (1)

HA6 2RN

Mount Vernon Cancer Centre at Mount Vernon Hospital, Northwood

Sponsors

Lead Sponsor

Cancer Research UK
All Listed Sponsors
lead

Cancer Research UK

OTHER